Derby 150mg Tablets 10s
Pay in 3 Installments of
Rs.
203
JazzCash
easypaisa
NayaPay
Bank transfer
Cash on Delivery
Description
Derby 150mg Tablets contain Itopride, a prokinetic agent that acts as a dopamine D2 antagonist and acetylcholinesterase inhibitor to enhance gastric motility. It is prescribed for adults with functional dyspepsia, gastroparesis, post-meal fullness, bloating, and chronic nausea caused by delayed gastric emptying.
Itopride promotes coordinated gastric contractions, accelerating food transit through the stomach and relieving discomfort. Unlike older prokinetics, it has a dual mechanism that offers improved efficacy with a low risk of cardiac side effects. Take as prescribed by your physician before meals.
Browse the full range of gastrointestinal medications in our GERD & Digestive Medicines collection, or see all Tablets & Capsules at Derma.pk. A valid prescription is required; submit via WhatsApp +92-320-5999650 or email sales@derma.pk.
Usage & Benefits
- Enhances gastric motility to relieve functional dyspepsia and gastroparesis
- Reduces post-meal fullness, bloating, and chronic nausea
- Dual-mechanism prokinetic with low cardiac risk versus older agents
- Supports coordinated gastric contractions and normal food transit
- Rx-only tablet from CCL Pharmaceuticals for safe, supervised use
How To Use
Take Derby 150mg Tablets as directed by your physician, typically before meals. Swallow with a full glass of water. Do not crush or chew. Do not discontinue without medical advice. A valid prescription is required.
FAQs
What is Derby 150mg used for?
Derby 150mg Tablets (Itopride) are prescribed for functional dyspepsia, gastroparesis, bloating, and post-meal fullness caused by delayed gastric emptying.
Is Derby 150mg a prescription medicine?
Yes, a valid prescription is required. Submit via WhatsApp +92-320-5999650 or email sales@derma.pk.
How does Itopride differ from other prokinetics?
Itopride works via dual dopamine D2 antagonism and acetylcholinesterase inhibition, providing effective gastric motility enhancement with a lower risk of cardiac side effects compared to older prokinetics like metoclopramide.
